Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Hayes

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Psychopharmacology|December 17, 2013
Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose studyRobert Risinger, Zubin Bhagwagar, Feng Luo, et al.
EJNMMI Research|March 13, 2012
Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studiesFloris Hp van Velden, Paul van Beers, Johan Nuyts, et al.
Radiology|May 29, 2014
Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter studyVirginie Frings, Floris H P van Velden, Linda M Velasquez, et al.
Psychopharmacology|August 14, 2014
Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836Ming Zheng, Lieuwe Appel, Feng Luo, et al.
Molecular Imaging and Biology|June 29, 2013
Test-retest variability of various quantitative measures to characterize tracer uptake and/or tracer uptake heterogeneity in metastasized liver for patients with colorectal carcinomaFloris H P van Velden, Ida A Nissen, Femke Jongsma, et al.
EJNMMI Research|January 5, 2012
Measurement of metabolic tumor volume: static versus dynamic FDG scansPatsuree Cheebsumon, Floris Hp van Velden, Maqsood Yaqub, et al.
Academic Radiology|December 9, 2009
Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarkerAndrew J Buckler, P David Mozley, Lawrence Schwartz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysisPatsuree Cheebsumon, Linda M Velasquez, Corneline J Hoekstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2020
Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using RadiomicsLaurent Dercle, Matthew Fronheiser, Lin Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2023
Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLCLaurent Dercle, Matthew Fronheiser, Naiyer A Rizvi, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Psychopharmacology|December 17, 2013
Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose studyRobert Risinger, Zubin Bhagwagar, Feng Luo, et al.
EJNMMI Research|March 13, 2012
Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studiesFloris Hp van Velden, Paul van Beers, Johan Nuyts, et al.
Radiology|May 29, 2014
Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter studyVirginie Frings, Floris H P van Velden, Linda M Velasquez, et al.
Psychopharmacology|August 14, 2014
Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836Ming Zheng, Lieuwe Appel, Feng Luo, et al.
Molecular Imaging and Biology|June 29, 2013
Test-retest variability of various quantitative measures to characterize tracer uptake and/or tracer uptake heterogeneity in metastasized liver for patients with colorectal carcinomaFloris H P van Velden, Ida A Nissen, Femke Jongsma, et al.
EJNMMI Research|January 5, 2012
Measurement of metabolic tumor volume: static versus dynamic FDG scansPatsuree Cheebsumon, Floris Hp van Velden, Maqsood Yaqub, et al.
Academic Radiology|December 9, 2009
Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarkerAndrew J Buckler, P David Mozley, Lawrence Schwartz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysisPatsuree Cheebsumon, Linda M Velasquez, Corneline J Hoekstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2020
Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using RadiomicsLaurent Dercle, Matthew Fronheiser, Lin Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2023
Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLCLaurent Dercle, Matthew Fronheiser, Naiyer A Rizvi, et al.
Pageof 4